DrugDashboards

Triple Antibiotic

First Aid Antibiotic · NEOMYCIN SULFATE 3.5 mg/g; BACITRACIN ZINC 400 [iU]/g; POLYMYXIN B SULFATE 5000 [iU]/g · Ointment · Topical · BluePoint Laboratories

NDC 68001-0483-45 · 1 TUBE in 1 CARTON / 28.4 g in 1 TUBE · OTC MONOGRAPH DRUG · View full market →

The short version

6 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.1104 per gram over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

$0$0.05$0.1$0.15Nov 2021Sep 2026$0.1104
59 price points · per GMSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$4.83
Reported to Texas DSHS · 2026 annual filing · Blue Point Laboratories

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$71,765
5,792 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for first aid antibiotic (other) in the next 90 days

sole-source market · price up 2% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
M004
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of First Aid Antibiotic (Ointment)

LabelerStrengthFirst seenLast seen
Aldermed Inc.BACITRACIN ZINC 500 [USP'U]/gJul 15, 2026Sep 2, 2026
BluePoint LaboratoriesBACITRACIN ZINC 500 [USP'U]/gJul 15, 2026Sep 2, 2026
BluePoint LaboratoriesNEOMYCIN SULFATE 3.5 mg/g; BACITRACIN ZINC 400 [iU]/g; POLYMYXIN B SULFATE 5000 [iU]/gAug 26, 2026Sep 2, 2026
Cardinal Health 110, Inc.BACITRACIN ZINC 500 [USP'U]/g; POLYMYXIN B SULFATE 10000 [USP'U]/gJul 15, 2026Sep 2, 2026
Dynarex CorporationBACITRACIN ZINC 500 [USP'U]/gJul 15, 2026Sep 2, 2026
Encube Ethicals, Inc.BACITRACIN ZINC 500 [USP'U]/gJul 15, 2026Sep 2, 2026
Veridian HealthcareBACITRACIN ZINC 500 [USP'U]/gJul 15, 2026Sep 2, 2026
BluePoint LaboratoriesNEOMYCIN SULFATE 400 [iU]/g; BACITRACIN ZINC 3.5 mg/g; POLYMYXIN B SULFATE 5000 [iU]/gJul 22, 2026Aug 19, 2026
BluePoint LaboratoriesBACITRACIN ZINC 400 [iU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [iU]/gJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Triple Antibiotic — NDC 68001-0483-45," retrieved September 3, 2026, https://drugdashboards.com/drug/68001048345.

Free to cite with attribution — see how the data is put together.